Risk factors of medication-related osteonecrosis of the jaw: a retrospective study in a Turkish subpopulation


Creative Commons License

ŞAHİN O., Odabasi O., Aliyev T., Tatar B.

JOURNAL OF THE KOREAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS, cilt.45, sa.2, ss.108-115, 2019 (ESCI, Scopus)

Özet

Objectives: Medication-related osteonecrosis of the jaw (MRONJ) is a well-known side effect of certain drugs that are used to influence bone metabolism to treat osteometabolic disease or cancers. The purpose of our study was to investigate how high-concentration and low-concentration bisphosphonate (BP) intake affects the disease severity.